NCT02741297 is a NA clinical trial of Spinal Cord Stimulation (SCS) System in Chronic Pain, sponsored by Boston Scientific Corporation.

Who is sponsoring NCT02741297?

NCT02741297 is sponsored by Boston Scientific Corporation.

What drugs are being tested in NCT02741297?

Interventions in NCT02741297: Spinal Cord Stimulation (SCS) System.

What condition does NCT02741297 study?

NCT02741297 studies Chronic Pain.

Is NCT02741297 still recruiting?

NCT02741297 is currently completed. Last updated 5 January 2021.

Are results published for NCT02741297?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-01-05 · How we verify

NCT02741297

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

VELOCITY: A Study to Characterize Real-World Outcomes of Spinal Cord Stimulation

Completed NA Results posted Last updated 5 January 2021

What this trial tests

NA trial testing Spinal Cord Stimulation (SCS) System in Chronic Pain in 73 participants. Completed in 25 June 2019.

Timeline

19 April 2016

Primary endpoint
21 September 2018

25 June 2019

Quick facts

Lead sponsor	Boston Scientific Corporation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	73
Start date	19 April 2016
Primary completion	21 September 2018
Estimated completion	25 June 2019
Sites	5 locations across Italy, Netherlands, Germany, United Kingdom

Drugs / interventions tested

Spinal Cord Stimulation (SCS) System

Conditions studied

Chronic Pain — all drugs for Chronic Pain →

Sponsor

Boston Scientific Corporation — full company profile →

Who can join

18 and older, any sex, with Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Percentage of Low Back Pain Responders Primary · 3 months

Percentage of low back pain responders at 3 months post-activation with no increase in opioids from Baseline to 3 months post-activation

All Subjects

Group	Value	95% CI
Spinal Cord Stimulation (SCS) System	25

All subjects without outliers

Group	Value	95% CI
Spinal Cord Stimulation (SCS) System	23

Adverse events — posted to ClinicalTrials.gov

Time frame: Up to 1 year. Reporting threshold: 5%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Spinal Cord Stimulation (SCS) System

Serious: 6/73 (8%)

Deaths: 0/73

Serious adverse events (8 terms)

Reaction	System	Spinal Cord Stimulation (S…
Angina Unstable	Cardiac disorders	—
Coronary Artery Disease	Cardiac disorders	—
Flank Pain	Musculoskeletal and connective tissue disorders	—
Tenosynovitis	Musculoskeletal and connective tissue disorders	—
Constipation	Gastrointestinal disorders	—
Hepatitis	Hepatobiliary disorders	—
Pneumonia	Infections and infestations	—
Circulatory Collapse	Vascular disorders	—

Other adverse events (1 terms — click to expand)

Reaction	System	Spinal Cord Stimulation (S…
Implant Site Infection	Infections and infestations	—

Most-reported serious reactions: Angina Unstable, Coronary Artery Disease, Flank Pain, Tenosynovitis, Constipation, Hepatitis, Pneumonia, Circulatory Collapse.

Data from ClinicalTrials.gov NCT02741297 adverse events section.

Sponsor's own description

The primary objective of this study is to characterize the real-world outcomes of spinal cord stimulation (SCS) therapy as an aid in the management of chronic intractable pain of the trunk, including unilateral or bilateral pain associated with the following: failed back surgery syndrome, intractable low back pain using the Boston Scientific (BSC) PRECISION Spinal Cord Stimulator System with MultiWave Technology.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Spinal Cord Stimulation (SCS) System

Trials testing the same drug.

NCT07267715 — EVA: Evaluation of EVOKE Therapy Metrics Generated Using the Evoke System With EVA · not yet recruiting

Other recruiting trials for Chronic Pain

Currently open trials in the same condition.

NCT07491549 — The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity · NA · recruiting
NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
NCT07103135 — Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling · Phase 1 · recruiting
NCT06219408 — CIH Stepped Care for Co-occurring Chronic Pain and PTSD · NA · recruiting
NCT07270406 — Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing Pain · NA · recruiting

Other Boston Scientific Corporation trials

Trials by the same sponsor.

NCT07458243 — Registry of ENROUTE NPS in Conjunction With Carotid WALLSTENT · not yet recruiting
NCT07458217 — Combined CM and STN Stimulation for Motor Epilepsy · NA · not yet recruiting
NCT07276815 — OverStitch NXT Endoscopic Suture System · NA · not yet recruiting
NCT07353710 — A Study on the Acquisition of 2D ICE Images With the CHORUS IDx System in Subjects Undergoing an Ablation Procedure · NA · not yet recruiting
NCT07195708 — Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365') · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02741297 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston Scientific Corporation
Last refreshed: 5 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02741297.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing